Literature DB >> 17006656

Fos immunoreactivity in some locomotor neural centres of 6OHDA-lesioned rats.

Claire E Heise1, John Mitrofanis.   

Abstract

In this study, we explore Fos expression (a measure of cell activity) in three nuclei associated with locomotion, namely the zona incerta, pedunculopontine tegmental nucleus and cuneiform nucleus (the latter two form the mesencephalic locomotor region) in hemiparkinsonian rats. Sprague-Dawley rats had small volumes of either saline (control) or 6 hydroxydopamine (6OHDA) injected into the medial forebrain bundle, the major tract carrying dopaminergic nigrostriatal axons. After various post-lesion survival periods, ranging from 2 h to 28 days, rats were perfused with formaldehyde and their brains processed for routine tyrosine hydroxylase and Fos immunocytochemistry. Our results showed a significant increase (P < 0.05) in the number of strongly labelled Fos+ cells in the cuneiform nucleus in the 6OHDA-lesioned cases compared to the controls after 7 and 28 days survival periods. By contrast, there were no significant differences (P > 0.05) in the number of strong-labelled Fos+ cells in the zona incerta and pedunculopontine nucleus of 6OHDA-lesioned rats compared to controls at any survival period. Many of the Fos+ cells within the pedunculopontine and cuneiform nuclei were glutamatergic (35-60%), while none or very few were nitric oxide synthase+. In conclusion, we reveal an increase in the number of strongly labelled Fos+ cells within the cuneiform nucleus of the so-called defensive locomotive system in 6OHDA-lesioned rats. In relation to Parkinson disease, we suggest that this increase is associated with the akinesia or lack of movement seen in patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006656     DOI: 10.1007/s00429-006-0130-0

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  7 in total

Review 1.  Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board.

Authors:  Roger L Albin; D James Surmeier; Cecilia Tubert; Martin Sarter; Martijn L T M Müller; Nicolaas I Bohnen; William T Dauer
Journal:  Mov Disord       Date:  2018-11-06       Impact factor: 10.338

Review 2.  The pedunclopontine nucleus and Parkinson's disease.

Authors:  Cecilia Tubert; Daniel Galtieri; D James Surmeier
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

3.  Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.

Authors:  Bhooma R Aravamuthan; Debra A Bergstrom; Robin A French; Joseph J Taylor; Louise C Parr-Brownlie; Judith R Walters
Journal:  Exp Neurol       Date:  2008-06-09       Impact factor: 5.330

4.  Patterns of Cell Activity in the Subthalamic Region Associated with the Neuroprotective Action of Near-Infrared Light Treatment in MPTP-Treated Mice.

Authors:  Victoria E Shaw; Cassandra Peoples; Sharon Spana; Keyoumars Ashkan; Alim-Louis Benabid; Jonathan Stone; Gary E Baker; John Mitrofanis
Journal:  Parkinsons Dis       Date:  2012-05-14

5.  LFP Oscillations in the Mesencephalic Locomotor Region during Voluntary Locomotion.

Authors:  Brian R Noga; Francisco J Sanchez; Luz M Villamil; Christopher O'Toole; Stefan Kasicki; Maciej Olszewski; Anna M Cabaj; Henryk Majczyński; Urszula Sławińska; Larry M Jordan
Journal:  Front Neural Circuits       Date:  2017-05-19       Impact factor: 3.492

Review 6.  Integration of Descending Command Systems for the Generation of Context-Specific Locomotor Behaviors.

Authors:  Linda H Kim; Sandeep Sharma; Simon A Sharples; Kyle A Mayr; Charlie H T Kwok; Patrick J Whelan
Journal:  Front Neurosci       Date:  2017-10-18       Impact factor: 4.677

Review 7.  Zona incerta as a therapeutic target in Parkinson's disease.

Authors:  Krystyna Ossowska
Journal:  J Neurol       Date:  2019-08-02       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.